AI
Amgen Inc
🇺🇸XNAS.AMGNUnited StatesHealthcare
$375.36USDdown -0.39 (-0.1%)OpenDelayed3:27 PM
Price$375.36-0.39 (-0.1%)
Profile
- Healthcare
- Drug Manufacturers - General
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US0311621009
- CUSIP
- 031162100
Company
- Employees
- 31,500
- Headquarters
- Thousand Oaks, United States
- Website
- https://www.amgen.com
- CEO
- Mr. Robert A. Bradway
Market
- Shares outstanding
- 540.6M
- Market cap
- $203.05B
Key dates
- Next earnings
- Nov 3, 2026
Highlights
- Market cap
- $203.14B
- EPS LTM
- $16.07
- P/E LTM
- 22.28
- Div yield
- 2.71%
Fundamentals (LTM)
- Revenue
- $38.13B+9.23%up year on year
- Net income
- $8.74B+32.09%up year on year
- Gross margin
- 72.65%+12.69%up year on year
- Free cash flow
- $10.18B-4.05%down year on year
Other listings
- XBER.AMGBerlin Stock Exchange
- XMUN.AMGMunich Stock Exchange
- XSTU.AMGStuttgart Stock Exchange
- XHAM.AMGHamburg Stock Exchange
- XDUS.AMGDüsseldorf Stock Exchange
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.